Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population-Reference-Cited by-同舟云学术

Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population

Author:

Li Miao¹,Chen Rong²,Ji Baoyan¹,Fan Chunmei³,Wang Guanying⁴,Yue Chenli⁵,Jin Guoquan¹

Affiliation:

1. Department of Medicine Oncology, The Fifth People's Hospital of Qinghai Province, Xining, Qinghai 810007, P.R. China

2. Department of Medicine Oncology, The Affiliated Hospital of Qinghai University, Xining, Qinghai 810016, P.R. China

3. Department of Science and Education, The Fifth People's Hospital of Qinghai Province, Xining, Qinghai 810007, P.R. China

4. Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China

5. Department of Respiratory Medicine, Shaanxi Provincial Corps Hospital of Chinese People's Armed Police Force, Xi'an, Shaanxi 710054, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献